MiR-183 Regulates Proliferation of SW1990 Pancreatic Cancer Cell Line by Targeting PDCD4

LU Ying-ying, ZENG Yue, ZHENG Jun-yuan. et al

Abstract

To investigate the effect of miR-183 on the cell proliferation in SW1990 pancreatic cancer cell line by targeting programmed cell death factor 4(PDCD4). Methods The SW1990 pancreatic cancer cells were transfected with miR-183 mimics and inhibitors at different concentrations, the alteration of PDCD4 levels was observed at specific concentrations by qPCR and Western blot. The cellular proliferation of transfected cells was determined by MTT assay. The distribution of cell cycle and apoptosis was examined by flow cytometry (FCM) and Hoechst 33258 staining. The expression of B-cell lymphoma （bcl-2） was evaluated by Western blot. Results The miR-183 mimic and inhibitor (at concentrations of 50 nmol/L or 150 nmol/L) showed significantly increasing or decreasing effects on the levels ofmiR-183 respectively. The expression of PDCD4 was downregulated in the cells transfected with miR-183 mimics, while significantly upregulated in the cells treated with miR-183 inhibitors. Western blot showed that miR-183 inhibitors resulted in a marked decrease in the expression levels of bcl-2. The growth of SW1990 cells was obviously inhibited after anti-miR-183 treatment, while an increase of apoptosis cells proportion and cell cycle G0/G1 arrest were observed after miR-183 inhibitors transfection. Conclusion The miR-183 inhibitors could restrain cell proliferation, promote cell apoptosis and increase G0/G1 arrest in SW1990 pancreatic cancer cells, which may be possibly through targeting PDCD4.

 

Keywords: Pancreatic cancer, MiR-183, Apoptosis, Cell cycle, PDCD4 

 

Full Text:

PDF


References


BARON TH. KOZAREKR A. Preoperative biliary stents in pancreatic cancer-proceed with caution. N Engl J Med. 2010. 362(2):170-172.

TIE J.FAN D. Big roles of microRNAs in tumorigenesis and tumor development. Histol Histopathol, 2011, 26 ( 10): 1353- 1361.

CHOU J, SHAHI P, WERB Z. microRNA-mediated regulation of the tumor microenvironment. Cell Cycle, 2013, 12(20):3262-3271.

LOWERY AJ, MILLER N, DWYER RM, et al. Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer,2010( 10) :502.doi: 10.1186/1471-2407- 10-502.

PIERCE ML, WESTON MD, FRITZSCH B, et al. MicroRNA-183 family conservation and ciliated neurosensory organ expression. Evol Dev,2008,10(1); 106-113.

WANG C, MAO W, ZHENG S. MicroRNA-183 regulates Ezrin expression in lung cancer cells . FEBS Lett, 2008,582 (25/26);3663-3668.

SARVER AL, LI L, SUBRAMANIAN S. MicroRNA miR- 183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res,2010,70(23);9570-9580.

YU J, LI A, HONG SM. et al. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res, 2012, 18(4):981-992.

JANSEN AP, CAMALIER CE, COLBURN NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res, 2005,65 ( 14): 6034- 6041.

LANKAT-BUTTGEREIT В. GOKE R. The tumour suppressor Pdcd4; recent advances in the elucidation of function and regulation. Biol Cell.2009.101(6) s309-317.

SCHMID T, JANSEN AP, BAKER AR, et al. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res.2008.68(5): 1254-1260.

LIJ, FU H. XU C, et al. MiR-183 inhibits TGF-betal- induced apoptosis by downregulation of PIX'Dl expression in human hepatocellular carcinoma cells. BMC Cancer. 2010 (10):354. doi: 10. 1186/1471-2407-10-354.

YANG M, LIU R. LI X. et al. miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. Mol Cells,2014 .37( 12):873-880.


Refbacks

  • There are currently no refbacks.